Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer

[1] Heelan RT(1997)Magnetic resonance imaging of the postpneumonectomy chest: normal and abnormal findings J Thorac Imaging 12 200-208

[2] Panicek DM(2002)Systematic postoperative radiologic follow-up in patients with non-small cell lung cancer for detecting second primary lung cancer in stage IA Arch Surg 137 935-938

[3] Burt ME(2004)Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer Q J Nucl Med 48 119-142

[4] Caravelli JF(1994)Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy- Radiology 191 379-382

[5] Martini N(1995)-glucose J Thorac Cardiovasc Surg 110 130-139

[6] Bains M(1995)Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET) Int J Radiat Oncol Biol Phys 32 1495-1512

[7] Lamont JP(1995)Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings J Nucl Med 36 788-793

[8] Kakuda JT(1999)Detecting recurrent or residual lung cancer with FDG-PET Eur Respir J 14 1376-1380

[9] Smith D(2000)Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer Pneumologie 54 49-53

[10] Wagman LD(2001)Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in diagnosis of recurrent bronchial carcinoma J Nucl Med 42 1605-1613

[1] Heelan RT(1997)Magnetic resonance imaging of the postpneumonectomy chest: normal and abnormal findings J Thorac Imaging 12 200-208

[2] Panicek DM(2002)Systematic postoperative radiologic follow-up in patients with non-small cell lung cancer for detecting second primary lung cancer in stage IA Arch Surg 137 935-938

[3] Burt ME(2004)Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer Q J Nucl Med 48 119-142

[4] Caravelli JF(1994)Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy- Radiology 191 379-382

[5] Martini N(1995)-glucose J Thorac Cardiovasc Surg 110 130-139

[6] Bains M(1995)Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET) Int J Radiat Oncol Biol Phys 32 1495-1512

[7] Lamont JP(1995)Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings J Nucl Med 36 788-793

[8] Kakuda JT(1999)Detecting recurrent or residual lung cancer with FDG-PET Eur Respir J 14 1376-1380

[9] Smith D(2000)Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer Pneumologie 54 49-53

[10] Wagman LD(2001)Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in diagnosis of recurrent bronchial carcinoma J Nucl Med 42 1605-1613